CDH1 and gastric neoplasm: We have recently established a mouse model of DGC, in which E-cadherin (Cdh1) and p53 (Trp53) are inactivated specifically in gastric mucosae.8 The penetrance is 100% for gastric neoplasm, contributing to the unfavourable mortality of 50% within a year.